MIMEDX GROUP, INC. Cash Flow Statement
MDXG / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
MIMEDX GROUP, INC. generated $74M in operating cash flow in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.50 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $48.6M | $42.4M | $58.2M | -$30.2M | -$10.3M | -$49.3M | -$25.6M | -$30.0M | $64.7M | $390.0K | $29.4M | $6.2M | -$4.1M | -$7.7M | -$10.2M |
| Depreciation & Amortization | $14.9M | $6.0M | $3.4M | $3.3M | $4.4M | $5.8M | $6.5M | $5.9M | $4.1M | $3.3M | $1.8M | $1.2M | $637.0K | $465.0K | $446.5K |
| Operating Cash Flow | $74.0M | $66.2M | $26.8M | -$17.9M | -$2.0M | -$30.3M | -$39.4M | $35.8M | $62.9M | $23.8M | $18.8M | $16.8M | -$284.0K | -$3.3M | -$6.7M |
| Capital Expenditures | - | - | $2.0M | $1.5M | $3.2M | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | $24.8M | -$19.4M | -$5.2M | - | - | - | - | - | - | - | - | - | - |
| Share Buybacks | $0 | $0 | $9.5M | $0 | $0 | $900.0K | $0 | $7.6M | $68.3M | $10.4M | $40.1M | - | - | - | - |
| FCF Margin | - | - | 7.7% | -7.2% | -2.1% | - | - | - | - | - | - | - | - | - | - |